These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31162534)

  • 1. Disturbances in Insulin-Glucose Metabolism in Patients With Advanced Renal Disease With and Without Diabetes.
    Rahhal MN; Gharaibeh NE; Rahimi L; Ismail-Beigi F
    J Clin Endocrinol Metab; 2019 Nov; 104(11):4949-4966. PubMed ID: 31162534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
    Galindo RJ; Beck RW; Scioscia MF; Umpierrez GE; Tuttle KR
    Endocr Rev; 2020 Oct; 41(5):756-74. PubMed ID: 32455432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.
    Ling J; Ng JKC; Chan JCN; Chow E
    Front Endocrinol (Lausanne); 2022; 13():869899. PubMed ID: 35528010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [[GLYCEMIC CONTROL IN DIABETES MELLITUS PATIENTS WITH CHRONIC KIDNEY DISEASE – HOW TO CHOOSE HYPOGLYCEMIC AGENT]?].
    Baretić M; Lang VB
    Acta Med Croatica; 2016 Dec; 70(4-5):269-74. PubMed ID: 29087153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of diabetes mellitus in dialysis patients].
    Bondar' IA; Klimontov VV
    Ter Arkh; 2011; 83(12):73-7. PubMed ID: 22416450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice.
    Abe M; Okada K; Soma M
    Curr Drug Metab; 2011 Jan; 12(1):57-69. PubMed ID: 21303332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Basal-Bolus Insulin Regimen on Metabolic Control and Risk of Hypoglycemia in Patients With Diabetes Undergoing Peritoneal Dialysis.
    Gómez AM; Vallejo S; Ardila F; Muñoz OM; Ruiz ÁJ; Sanabria M; Bunch A; Morros E; Kattah L; García-Jaramillo M; León-Vargas F
    J Diabetes Sci Technol; 2018 Jan; 12(1):129-135. PubMed ID: 28927285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of diabetes mellitus in chronic kidney disease.
    Garla V; Kanduri S; Yanes-Cardozo L; Lién LF
    Minerva Endocrinol; 2019 Sep; 44(3):273-287. PubMed ID: 31112029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing diabetes in hospitalized patients with chronic kidney disease.
    Iyer SN; Tanenberg RJ
    Cleve Clin J Med; 2016 Apr; 83(4):301-10. PubMed ID: 27055204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Roussel R; Lorraine J; Rodriguez A; Salaun-Martin C
    Adv Ther; 2015 Nov; 32(11):1029-64. PubMed ID: 26581749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control in diabetic CKD patients: where do we stand?
    Kovesdy CP; Sharma K; Kalantar-Zadeh K
    Am J Kidney Dis; 2008 Oct; 52(4):766-77. PubMed ID: 18572289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic management in ESRD and earlier stages of CKD.
    Williams ME; Garg R
    Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S22-38. PubMed ID: 24461727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia in diabetes.
    Cryer PE; Davis SN; Shamoon H
    Diabetes Care; 2003 Jun; 26(6):1902-12. PubMed ID: 12766131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for glucose control in a study population with diabetes, renal disease and anemia (Treat study).
    Weinrauch LA; D'Elia JA; Finn P; Lewis EF; Desai AS; Claggett BL; Cooper ME; McGill JB
    Diabetes Res Clin Pract; 2016 Mar; 113():143-51. PubMed ID: 26830074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of diabetes mellitus in patients with chronic kidney disease].
    Bojunga J; Mondorf A
    Dtsch Med Wochenschr; 2019 Aug; 144(15):1044-1050. PubMed ID: 31350746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Acid-Base Homeostasis in Diabetic Kidney Disease.
    Khairallah P; Scialla JJ
    Curr Diab Rep; 2017 Apr; 17(4):28. PubMed ID: 28343312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and brain-derived neurotrophic factor levels in chronic kidney disease.
    Marchelek-Myśliwiec M; Cichocka E; Dziedziejko V; Dutkiewicz GŻ; Stępniewska J; Safranow K; Budkowska M; Sałata D; Syrenicz A; Machaliński B; Ciechanowski K
    Ann Clin Biochem; 2015 Mar; 52(Pt 2):213-9. PubMed ID: 24833633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.